Jason Conner

Jason's practice focuses on commercial and intellectual property transactions and strategic counsel in the pharmaceutical, biotech and life sciences industries, including:

• business development transactions, including in/out-licensing and development agreements, strategic alliances, product/candidate acquisition and divestitures, and research collaborations agreements;
• pharmaceutical and biotech outsourcing arrangements, including contract manufacturing (formulation, stability services, process development, API, fill & finish, and delivery systems), clinical services (CRO), and marketing agreements;
• biopharma supply chain, processing services, distribution, and co-promotion agreements;
• clinical trials contracting and compliance, including master service agreements, clinical trial agreements, investigator led study agreements, central laboratory agreements, clinical packaging and distribution agreements, and advising on clinical SOP development, IRB issues, inform consent forms, and other general compliance issues.

He has experience advising clients in a variety of industries, including pharmaceuticals, biologicals such as recombinant proteins, gene therapy, plasma-based therapeutics, vaccines, ag-bio and ag-chem.

Prior to joining LSL, Jason managed business development activities at Becton Dickinson's research and innovation division, BD Technologies, in areas including therapeutics, cell therapy and tissue engineering, biomaterials, drug delivery/devices, diagnostics and instrumentation platforms.

Jason holds a J.D. from the University of North Carolina School of Law. He received an M.S. (MBA) in Technology Commercialization from North Carolina State University College of Management and an M.A. from the University of Hawai'i. He holds a B.A. from the University of Pennsylvania. He is admitted to the bar of North Carolina.